We have previously shown that the epidermal growth factor receptor (EG
FR) ligand, amphiregulin (AR) exhibits low potency as a result of its
C-terminal truncation. This led us to investigate whether its inabilit
y to promote anchorage-independent growth (AIG) of normal cells arose
because of its compromised interaction with EGFR. Wild type AR(1-84) w
as tested in AIG and mitogenesis assays using NRK-49F or NRG/HER fibro
blasts. In contrast to NRG/HER cells, the response of NRK-49F fibrobla
sts to AR was much lower than expected. As the effect of AR was hepari
n-insensitive, contributions from heparan sulphate proteoglycan intera
ctions could not explain the differing sensitivities of the cells. Com
parison of the effects of AR on two additional cell lines indicated th
at low EGFR number correlated with AR insensitivity: this suggested th
at the low potency of AR precluded activation of sufficient receptors
to elicit a response. Consistent with this proposal, a modified form o
f AR (AR(1-90(leu86))) with enhanced potency was able to induce AIG of
NRK-49F fibroblasts. Thus, the ability of AR to promote AIG is determ
ined both by ligand potency and the EGFR complement of cells.